Preterm delivery was associated with maternal drug-treated hypertension and impaired renal function. A matched case-control study showed no evidence of increased renal allograft loss after pregnancy.

These data suggest that urinary angiotensinogen is a potentially suitable marker of intrarenal AngII activity associated with increased risk for deterioration of renal function in patients with CKD.

In the laboratory examination the counting of WBC, neutrophile granulocyte increased, while leukomonocyte decreased. The renal function index, fibrinogen index became abnormal.